2019
DOI: 10.1016/j.bjane.2019.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Capsaicin topical cream (8%) for the treatment of myofascial pain syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…A total of 942 titles (PubMed, 84; Ovid SP, 839; Cochrane, 19) was retrieved, of which 936 were excluded based on the title and abstract. A total of 11 studies was further evaluated for full text analysis, of which 7 were excluded 15 - 21 ( Table 1 ), leaving 4 articles for the qualitative analysis. ( Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…A total of 942 titles (PubMed, 84; Ovid SP, 839; Cochrane, 19) was retrieved, of which 936 were excluded based on the title and abstract. A total of 11 studies was further evaluated for full text analysis, of which 7 were excluded 15 - 21 ( Table 1 ), leaving 4 articles for the qualitative analysis. ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…A total of 942 titles (PubMed, 84; Ovid SP, 839; Cochrane, 19) was retrieved, of which 936 were excluded based on the title and abstract. A total of 11 studies was further evaluated for full text analysis, of which 7 were excluded [15][16][17][18][19][20][21] (Table 1), 20 (2006) Model study for identifying pathophysiology of burning mouth syndrome. 3 Epstein and Marcoe 17 (1994) Capsaicin is used for neuropathic pain and trigeminal neuralgia.…”
Section: Study Selectionmentioning
confidence: 99%
“…The addition of one trial of duloxetine (n=236) 9 to an updated meta-analysis did not change prior conclusions of no effect of serotonin-norepinephrine reuptake inhibitors (SNRIs) on the risk of serious adverse events (SAEs) (20 RCTs, N=9,059, 1.6% vs. 2.6%, RR 0.92, 95% CI, 0.65 to 1.29, I 2 =0%) 9,[23][24][25][26][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43] and a moderate risk of withdrawals due to adverse events (WAEs) (25 RCTs, N=10,207, 15.2% vs. 7.4%, RR 2.00, 95% CI, 1.72 to 2.35, I 2 =18%). 9,[23][24][25][26][27][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47]…”
Section: Serotonin-norepinephrine Reuptake Inhibitormentioning
confidence: 99%
“…Romero et al [ 10 ] reported that the local application of 8% Capsaicin cream is beneficial and well-tolerated by patients with myofascial pain syndrome.…”
Section: Introductionmentioning
confidence: 99%